"Hematological malignancies" trang 1 - tải miễn phí từ tailieunhanh
Ebook HIV-associated hematological malignancies: Part 2

Ebook HIV-associated hematological malignancies: Part 2
114    123    0
Ebook HIV-associated hematological malignancies: Part 1

Ebook HIV-associated hematological malignancies: Part 1
125    99    0
Ebook HIV-Associated hematological malignancies (E): Part 1

Ebook HIV-Associated hematological malignancies (E): Part 1
125    98    0
Ebook HIV-Associated hematological malignancies (E): Part 2

Ebook HIV-Associated hematological malignancies (E): Part 2
114    102    0
Distribution and features of hematological malignancies in Eastern Morocco: A retrospective multicenter study over 5 years

Distribution and features of hematological malignancies in Eastern Morocco: A retrospective multicenter study over 5 years
10    58    1
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
6    72    0
Long-term effects and psychological adjustment: Study protocol of a large register-based study on quality of life among survivors of hematological malignancies

Long-term effects and psychological adjustment: Study protocol of a large register-based study on quality of life among survivors of hematological malignancies
10    57    1
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies

Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies
17    32    1
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy

Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
8    8    1
Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: Protocol of an interview-based study according to updated diagnostic criteria

Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: Protocol of an interview-based study according to updated diagnostic criteria
9    88    0
Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals

Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals
7    36    1
báo cáo khoa học:

báo cáo khoa học: "Role of Wnt canonical pathway in hematological malignancies"
6    68    0
báo cáo khoa học:

báo cáo khoa học: "Mechanism of action of lenalidomide in hematological malignancies"
10    73    0
Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy

Recent progress in improving the safety and efficacy of chimeric antigen receptor T cell therapy
10    52    0
Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study

Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study
12    58    1
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study

The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
12    33    1
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: Implications of using serum TK1 as a biomarker

Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: Implications of using serum TK1 as a biomarker
12    70    1
Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
10    40    1
Cerebral lesions in hematological malignancies: A case report

Cerebral lesions in hematological malignancies: A case report
7    16    1
A new insight into acute lymphoblastic leukemia in children: Influences of changed intestinal microfloras

A new insight into acute lymphoblastic leukemia in children: Influences of changed intestinal microfloras
9    44    1